Table 3.
Discharge medications after SCAD event by time quintiles.
| Medications | Before 2013 (n = 32) |
2013–2016 (n = 29) |
2017 (n = 29) |
2018 (n = 28) |
2019 (n = 27) |
p-value |
|---|---|---|---|---|---|---|
| ASA | 29 (91) | 28 (97) | 29 (100) | 28 (100) | 27 (100) | 0.105 |
| DAPT | 18 (56) | 19 (66) | 21 (72) | 22 (79) | 22 (82) | 0.203 |
| Statins | 15 (47) | 21 (72) | 24 (83) | 23 (82) | 24 (89) | 0.002 |
| Beta-blockers | 25 (78) | 25 (86) | 26 (90) | 23 (82) | 25 (93) | 0.529 |
| ACEi/ARB | 12 (38) | 10 (34) | 10 (34) | 11 (39) | 13 (48) | 0.831 |
Data presented as n (%).
Bold p-values were statistically significant (p<0.05)
ACEi, angiotensin-converting enzyme inhibitor; ARB, angiotensin receptor blocker; ASA, aspirin; DAPT, dual antiplatelet therapy; SCAD, spontaneous coronary artery dissection.